Doctors Drug Trials Genetics Research 
Drug Discovery World
NOVEMBER 7, 2022
A new study led by Medical Research Council-funded researchers from UCL has found that tailoring the analysis of whole genome sequencing to individual patients could double the diagnostic rates of rare diseases. . It can also permit targeted screening of known disease complications and access to drug studies. Context .
pharmaphorum
AUGUST 25, 2022
That was until my doctors stunned me with the news that I had cirrhosis caused by non-alcoholic steatohepatitis, or NASH, a severe form of fatty liver disease that often has few or no symptoms until very late stages. Cirrhosis is not just an “old drunk guys” disease, a stigma which has long hampered interest and investment in research.
XTalks
FEBRUARY 25, 2022
And Black people continue to face generational disenfranchisement in healthcare systems and medical research. The overwhelming majority of trial participants nationwide are white. However, the links between race-based genetics and disease are not quite clear. They are also at a high risk of developing heart disease and stroke.
Expert insights. Personalized for you.
52 
Let's personalize your content